Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-01-22

FDA Approved: VALSARTAN — Supplemental Application (Unichem Pharmaceuticals (USA), Inc.)

View source ↗

Summary

FDA approved a supplemental application from Unichem Pharmaceuticals (USA), Inc. for valsartan (generic valsartan) under an ANDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • VALSARTAN (Valsartan)

Snippet

SUPPL AP for VALSARTAN (VALSARTAN)